Mannitol IV 20% Injection
Marketer
Abbott
Salt Composition
Mannitol (20% w/v)
Overview Mannitol IV 20% Injection
Twenty percent mannitol intravenous injection is a therapeutic agent employed in managing acute kidney failure, reducing intracranial pressure from cerebral edema, and lowering intraocular pressure in glaucoma. Its mechanism involves diuresis and anti-inflammatory action, targeting excess fluid. This medication, administered intravenously by a healthcare provider, may be used independently or adjunctively with other treatments. Dosage and duration should strictly adhere to the physician's instructions. Missed doses should be taken immediately upon recollection. Typical adverse effects include nausea, vomiting, headache, and dehydration; injection site reactions such as pain, redness, or swelling are also possible, though generally transient. Persistent or bothersome side effects necessitate medical consultation. Routine blood monitoring may be necessary during treatment.
Uses of Mannitol IV 20% Injection
Sudden kidney failure | Brain swelling due to fluid buildup | Increased intraocular pressure
Major Benefits of Mannitol IV 20% Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Mannitol IV 20% Injection:
- Nausea
- Vomiting
- Headache
- Dehydration
- Injection site reactions (pain, swelling, redness)
How to use Mannitol IV 20% Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Mannitol IV 20% Injection works:
Administering a 20% mannitol solution intravenously leverages its osmotic properties. This inert agent draws fluid into the renal system, thereby augmenting urinary output. Furthermore, intravenous 20% mannitol is indicated for reducing intraocular pressure or cerebral edema.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption while receiving Mannitol IV 20% Injection is undetermined. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Administering 20% mannitol intravenous injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescription. Patient consultation with their doctor is advised.
Breast feedingSAFE IF PRESCRIBED
Administering 20% mannitol intravenous injection while breastfeeding appears to pose minimal risk. Available human data indicate negligible infant harm.
DrivingSAFE
Administration of 20% mannitol intravenous injection typically does not impair driving ability.
KidneySAFE IF PRESCRIBED
Administration of 20% mannitol injection intravenously is likely safe for individuals with impaired renal function. Current evidence indicates that dose modification of 20% mannitol intravenous injection might not be necessary for this population. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of 20% mannitol intravenous injection to individuals with hepatic impairment. Seek medical advice from your physician.
What if you forget to take Mannitol IV 20% Injection :
Omit a dose of Mannitol 20% IV Injection? Seek immediate medical advice.
Facts to Know About Mannitol IV 20% Injection
| Label | Value |
|---|---|
| Type of Compound | Polyols |
| Addictive | None. |
| Medication Classification | HEART |
| Mechanism of Action | Drugs that increase urine output through osmotic action |
3,018 People bought this recently
